High prevalence and correlates of low bone mineral density in young adults with sickle cell disease

被引:92
作者
Miller, RG
Segal, JB
Ashar, BH
Leung, S
Ahmed, S
Siddique, S
Rice, T
Lanzkron, S
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Div Gen Internal Med, Baltimore, MD 21218 USA
[2] Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21218 USA
关键词
osteoporosis; sickle cell disease; bone mineral density; DXA;
D O I
10.1002/ajh.20541
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sickle cell disease (SCD) is a prevalent genetic disorder in which sickle hemoglobin leads to tissue hypoxia and adverse effects on bone. Published studies suggest that children with SCD often have undiagnosed osteopenia or osteoporosis. Minimal data exist on the prevalence of low bone mineral density (BMD) in adults. Our objective was to describe the prevalence of osteopenia and osteoporosis in adults with SCD and to identify patient or disease characteristics associated with low BMD. We conducted a cross-sectional study of adults with SCD. Through questionnaires, we collected data about disease course and osteoporosis risk factors. Patients underwent dual X-ray absorptiometry (DXA) measurement of BMD; at the hip, spine, and forearm and sampling of blood and urine for markers of bone turnover, sickle cell disease severity, and secondary causes of osteoporosis. Our main outcome measure was prevalence of osteopenia and osteoporosis as defined by WHO criteria. Of 32 adults with SCD (14 men and 18 women) with a mean age of 34 years, 72% (95% confidence interval 53-86%) had low BMD at one or more anatomic sites. Thirteen patients were classified as osteoporotic and 10 as osteopenic. The prevalence of low BMD was greatest in the lumbar spine (66% of patients). Significant correlates of decreased BMD included low BMI (P < 0.01), male sex (P = 0.02), and low serum zinc concentrations (P < 0.01). The prevalence of osteopenia and osteoporosis in young adults with SCD is extremely high. Further research is needed to address fracture risk and therapeutic interventions.
引用
收藏
页码:236 / 241
页数:6
相关论文
共 31 条
[1]  
ALEXEEVA L, 1994, WHO TECH REP SER, V843, P1
[2]   Bone involvement in sickle cell disease [J].
Almeida, A ;
Roberts, I .
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (04) :482-490
[3]   Body composition in children with sickle cell disease [J].
Barden, EM ;
Kawchak, DA ;
Ohene-Frempong, K ;
Stallings, VA ;
Zemel, BS .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2002, 76 (01) :218-225
[4]   Estimating hip fracture morbidity, mortality and costs [J].
Braithwaite, RS ;
Col, NF ;
Wong, JB .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2003, 51 (03) :364-370
[5]  
Brinker M R, 1998, Am J Orthop (Belle Mead NJ), V27, P43
[6]   EFFECT OF HYDROXYUREA ON THE FREQUENCY OF PAINFUL CRISES IN SICKLE-CELL-ANEMIA [J].
CHARACHE, S ;
TERRIN, ML ;
MOORE, RD ;
DOVER, GJ ;
BARTON, FB ;
ECKERT, SV ;
MCMAHON, RP ;
BONDS, DR ;
ORRINGER, E ;
JONES, S ;
STRAYHORN, D ;
ROSSE, W ;
PHILLIPS, G ;
PEACE, D ;
JOHNSONTELFAIR, A ;
MILNER, P ;
KUTLAR, A ;
TRACY, A ;
BALLAS, SK ;
ALLEN, GE ;
MOSHANG, J ;
SCOTT, B ;
STEINBERG, M ;
ANDERSON, A ;
SABAHI, V ;
PEGELOW, C ;
TEMPLE, D ;
CASE, E ;
HARRELL, R ;
CHILDERIE, S ;
EMBURY, S ;
SCHMIDT, B ;
DAVIES, D ;
KOSHY, M ;
TALISCHYZAHED, N ;
DORN, L ;
PENDARVIS, G ;
MCGEE, M ;
TELFER, M ;
DAVIS, A ;
CASTRO, O ;
FINKE, H ;
PERLIN, E ;
SITEMAN, J ;
GASCON, P ;
DIPAOLO, P ;
GARGIULO, S ;
ECKMAN, J ;
BAILEY, JH ;
PLATT, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (20) :1317-1322
[7]   RISK-FACTORS FOR HIP FRACTURE IN WHITE WOMEN [J].
CUMMINGS, SR ;
NEVITT, MC ;
BROWNER, WS ;
STONE, K ;
FOX, KM ;
ENSRUD, KE ;
CAULEY, JC ;
BLACK, D ;
VOGT, TM .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (12) :767-773
[8]   Hypogonadism in men consuming sustained-action oral opioids [J].
Daniell, HW .
JOURNAL OF PAIN, 2002, 3 (05) :377-384
[9]   DIFFERENCES IN OUTCOME BETWEEN BLACK-AND-WHITE ELDERLY HIP FRACTURE PATIENTS [J].
FURSTENBERG, AL ;
MEZEY, MD .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (10) :931-938
[10]   The role of trace minerals in the pathogenesis of postmenopausal osteoporosis and a new effect of calcitonin [J].
Gür, A ;
Çolpan, L ;
Nas, K ;
Çevik, R ;
Saraç, J ;
Erdogan, F ;
Düz, MZ .
JOURNAL OF BONE AND MINERAL METABOLISM, 2002, 20 (01) :39-43